Detalhe da pesquisa
1.
The comparison of four hypoxia-inducible factor prolyl hydroxylase inhibitors on drug potency and cost for treatment in patients with renal anemia.
Clin Exp Nephrol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767688
2.
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
J Am Soc Nephrol
; 34(6): 955-968, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918388
3.
Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.
Clin Exp Nephrol
; 27(9): 757-766, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289335
4.
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
J Am Soc Nephrol
; 33(2): 291-303, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862238
5.
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
Am J Nephrol
; 53(2-3): 226-239, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226897
6.
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS).
Clin Exp Nephrol
; 26(12): 1170-1179, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962244
7.
Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan.
Clin Exp Nephrol
; 25(2): 110-119, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949295
8.
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Clin Exp Nephrol
; 24(6): 526-540, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32146646
9.
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS).
Clin Exp Nephrol
; 24(10): 893-909, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32562107
10.
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.
J Am Soc Nephrol
; 30(9): 1756-1769, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292198
11.
A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression.
Kidney Blood Press Res
; 44(3): 362-383, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31203292
12.
Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
Clin Exp Nephrol
; 23(2): 215-222, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30168046
13.
Correction to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
Clin Exp Nephrol
; 23(1): 99, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30094596
14.
Analysis of 2897 hospitalization events for patients with chronic kidney disease: results from CKD-JAC study.
Clin Exp Nephrol
; 23(7): 956-968, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30968244
15.
Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.
Clin Exp Nephrol
; 23(2): 231-243, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30182223
16.
Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
Clin Exp Nephrol
; 23(1): 85-98, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29951723
17.
Visit-to-visit variability in estimated glomerular filtration rate predicts hospitalization and death due to cardiovascular events.
Clin Exp Nephrol
; 23(5): 661-668, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30687876
18.
Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.
Clin Exp Nephrol
; 23(3): 435, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30673934
19.
Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).
Clin Exp Nephrol
; 22(1): 78-84, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28660446
20.
Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Clin Exp Nephrol
; 22(6): 1266-1280, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29679356